Items Tagged ‘Stage I Ovarian Cancer’

October 31st, 2016

Update on PARP Inhibitors for Ovarian Cancer with BRCA Mutations

By

Each year in the United States, roughly 22,000 women are diagnosed with ovarian cancer and more than 15,000 die of the disease. Treatment for ovarian cancer commonly involves surgery and/or chemotherapy. Researchers continue to study new approaches for improving the outcomes of all women affected by ovarian cancer but progress has been slow. The PARP […]

View full entry

Tags: BRCA1, BRCA2, lynparza, News, niraparib, olaparib, Ovarian Cancer, PARP inhibitor, Recurrent Ovarian Cancer, Rucaparib, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer


September 28th, 2015

Intraperitoneal Chemotherapy Underused in Ovarian Cancer

By

The use of intraperitoneal (IP) chemotherapy appears to be utilized in fewer than 50% of clinical practices, despite results indicating improved survival with its use in certain patients with ovarian cancer. These results were recently published in the Journal of Clinical Oncology. IP chemotherapy refers to chemotherapy that is delivered directly into the pelvis/abdominal area, […]

View full entry

Tags: intraperitoneal chemotherapy, IP, IV chemotherapy, News, Ovarian Cancer, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer


February 20th, 2014

Aspirin as Ovarian Cancer Prevention? Research Says Maybe

By

New evidence suggests that an aspirin a day may reduce the risk of ovarian cancer. But more research is needed before your doctor will routinely prescribe it for prevention. You may know that low doses of aspirin, taken daily, can help reduce the risk of several serious health issues. Studies have also found that an […]

View full entry

Tags: News, Ovarian Cancer, Recurrent Ovarian Cancer, Screening/Prevention Ovarian Cancer, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer


February 7th, 2013

Ovarian Cancer Rates Declining in Breast Cancer Survivors

By

The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed with ovarian cancer and more than 15,000 die of the disease. Overall incidence […]

View full entry

Tags: News, Ovarian Cancer, Recurrent Ovarian Cancer, Screening/Prevention Ovarian Cancer, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer


December 3rd, 2012

Diabetes Drug May Help Prevent or Treat Ovarian Cancer

By

Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results of a study published in Cancer.[1] Each year in the United States, roughly 22,000 women are diagnosed […]

View full entry

Tags: News, Ovarian Cancer, Recurrent Ovarian Cancer, Screening/Prevention Ovarian Cancer, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer


November 20th, 2012

Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients

By

Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of lower complication rates, but of a better response to complications. Each year in the United […]

View full entry

Tags: News, Ovarian Cancer, Recurrent Ovarian Cancer, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer


September 28th, 2012

Gene Helps Predict Response to Chemotherapy in Ovarian Cancer

By

Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British Journal of Cancer. Each year in the United States, roughly 22,000 women are diagnosed with ovarian cancer and more than 15,000 die of the […]

View full entry

Tags: News, Ovarian Cancer, Recurrent Ovarian Cancer, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer


October 24th, 2011

BRCA Genes May Influence Ovarian Cancer Outcomes

By

Among women with ovarian cancer, those who have a BRCA2 gene mutation may have a better response to chemotherapy and longer survival than those who do not have a BRCA gene mutation. These results were published in the Journal of the American Medical Association. Inherited mutations in two genes—BRCA1 and BRCA2—have been found to greatly […]

View full entry

Tags: News, Ovarian Cancer, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer


June 6th, 2011

Avastin Shows Benefit in Ovarian Cancer

By

The addition of the targeted drug Avastin® (bevacizumab) to chemotherapy may improve outcomes among women with newly diagnosed or recurrent ovarian cancer. These results—from two Phase III clinical trials—were presented at the 2011 annual meeting of the American Society of Clinical Oncology. Treatment for ovarian cancer commonly involves surgery and/or chemotherapy. Outcomes for women diagnosed […]

View full entry

Tags: News, Ovarian Cancer, Recurrent Ovarian Cancer, Stage I Ovarian Cancer, Stage II-IV Ovarian Cancer